niacinamide has been researched along with Heart Disease, Ischemic in 53 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These experiments were designed to explore the possibility that a K+ channel opener which also donates nitric oxide to the myocardium (nicorandil) may modify ischaemia-induced ventricular arrhythmias in a large animal model." | 7.69 | Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia. ( Györgyi, K; Papp, JG; Parratt, JR; Sakai, K; Vegh, A, 1996) |
| "Effects of CD-832 on isoproterenol (ISO)-induced myocardial ischemia were studied in dogs with partial coronary stenosis of the left circumflex coronary artery and findings were compared with those for nifedipine or diltiazem." | 7.69 | Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis. ( Araki, H; Higuchi, S; Kishi-Tanikawa, S; Takahashi, K; Takahashi, T; Tsuchida, K, 1996) |
| "We report five patients who developed intraoperative myocardial ischemia but were treated successfully with nicorandil." | 7.69 | [Successful treatment of intraoperative myocardial ischemia with nicorandil]. ( Hanaoka, K; Hayashida, M; Ito, N; Kawamura, S; Komatsu, K; Kuzumi, E; Orii, R; Sawamura, S, 1997) |
| "Nicorandil treatment did not change the altered heart rate variability in either time domain or spectral analysis." | 6.68 | Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. ( Chang, MS; Chen, JW; Hsu, NW; Lee, WL; Lin, SJ; Ting, CT; Wang, SP, 1997) |
| " The aim of the studies was to establish the effects of sublingually or orally applied nicorandil (N) on pacing-induced myocardial ischemia (MIS)." | 4.79 | Effects of nicorandil on regional perfusion and left ventricular function. ( Berwing, K; Mitrovic, V; Schlepper, M; Strasser, R; Thormann, J, 1995) |
| "These experiments were designed to explore the possibility that a K+ channel opener which also donates nitric oxide to the myocardium (nicorandil) may modify ischaemia-induced ventricular arrhythmias in a large animal model." | 3.69 | Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia. ( Györgyi, K; Papp, JG; Parratt, JR; Sakai, K; Vegh, A, 1996) |
| "Effects of CD-832 on isoproterenol (ISO)-induced myocardial ischemia were studied in dogs with partial coronary stenosis of the left circumflex coronary artery and findings were compared with those for nifedipine or diltiazem." | 3.69 | Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis. ( Araki, H; Higuchi, S; Kishi-Tanikawa, S; Takahashi, K; Takahashi, T; Tsuchida, K, 1996) |
| "We report five patients who developed intraoperative myocardial ischemia but were treated successfully with nicorandil." | 3.69 | [Successful treatment of intraoperative myocardial ischemia with nicorandil]. ( Hanaoka, K; Hayashida, M; Ito, N; Kawamura, S; Komatsu, K; Kuzumi, E; Orii, R; Sawamura, S, 1997) |
| "Myocardial ischemia was measured as the magnitude of ST-segment elevation on the intracoronary electrocardiogram (intracoronary ECG) recorded from the guidewire." | 2.68 | Antiischemic effects of nicorandil during coronary angioplasty in humans. ( Fukui, T; Hibiya, K; Honye, J; Kamata, T; Mizumura, T; Moriuchi, M; Ozawa, Y; Saito, S; Takayama, T; Tamura, Y, 1995) |
| "Nicorandil treatment did not change the altered heart rate variability in either time domain or spectral analysis." | 2.68 | Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. ( Chang, MS; Chen, JW; Hsu, NW; Lee, WL; Lin, SJ; Ting, CT; Wang, SP, 1997) |
| "Nicorandil is a balanced arterial and venodilator that may also possess cardioprotective properties via its activation of ATP-sensitive potassium channels." | 2.39 | Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil. ( Fox, K; Knight, C; Purcell, H, 1995) |
| "Nicorandil is a new vasodilator agent." | 2.38 | Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. ( Krumenacker, M; Roland, E, 1992) |
| "Type 2 diabetes was induced by injection of streptozotocin and nicotinamide." | 1.43 | Effects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats. ( Bageripour, F; Ghanbari, M; Ghasemi, A; Jeddi, S; Khalifi, S, 2016) |
| "Treatment with small molecule tyrosine kinase inhibitors (TKIs) has improved survival in many cancers, yet has been associated with an increased risk of adverse events." | 1.42 | Cardiovascular toxicity of multi-tyrosine kinase inhibitors in advanced solid tumors: a population-based observational study. ( Amir, E; Ethier, JL; Krzyzanowska, MK; Ocana, A; Seruga, B; Srikanthan, A, 2015) |
| "Nicorandil is a compound with hybrid properties of nitrates and adenosine triphosphate (ATP)-sensitive potassium channel (KATP) opening." | 1.29 | Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. ( Branzi, A; Galiè, N; Guarnieri, C; Magnani, B; Parlangeli, R; Traini, AM; Ussia, GP; Vaona, I; Zimarino, M, 1995) |
| "Nicorandil is a clinically used nitrovasodilator that has a property as an opener of ATP-sensitive potassium (KATP) channels in vitro." | 1.29 | Nicorandil augments regional ischemia-induced monophasic action potential shortening and potassium accumulation without serious proarrhythmia. ( Asanagi, M; Mitamura, H; Miyazaki, T; Miyoshi, S; Moritani, K; Ogawa, S; Zhao, LS, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.89) | 18.7374 |
| 1990's | 44 (83.02) | 18.2507 |
| 2000's | 3 (5.66) | 29.6817 |
| 2010's | 5 (9.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferraris, D | 1 |
| Ko, YS | 1 |
| Pahutski, T | 1 |
| Ficco, RP | 1 |
| Serdyuk, L | 1 |
| Alemu, C | 1 |
| Bradford, C | 1 |
| Chiou, T | 1 |
| Hoover, R | 1 |
| Huang, S | 1 |
| Lautar, S | 1 |
| Liang, S | 1 |
| Lin, Q | 1 |
| Lu, MX | 1 |
| Mooney, M | 1 |
| Morgan, L | 1 |
| Qian, Y | 1 |
| Tran, S | 1 |
| Williams, LR | 1 |
| Wu, QY | 1 |
| Zhang, J | 1 |
| Zou, Y | 1 |
| Kalish, V | 1 |
| Li, W | 1 |
| Zhu, L | 1 |
| Ruan, ZB | 1 |
| Wang, MX | 1 |
| Ren, Y | 1 |
| Lu, W | 1 |
| Srikanthan, A | 1 |
| Ethier, JL | 1 |
| Ocana, A | 1 |
| Seruga, B | 1 |
| Krzyzanowska, MK | 1 |
| Amir, E | 1 |
| Jeddi, S | 1 |
| Khalifi, S | 1 |
| Ghanbari, M | 1 |
| Bageripour, F | 1 |
| Ghasemi, A | 1 |
| Kang, SM | 1 |
| Park, JC | 1 |
| Shin, MJ | 1 |
| Lee, H | 1 |
| Oh, J | 1 |
| Ryu, DH | 1 |
| Hwang, GS | 1 |
| Chung, JH | 1 |
| Kardash, OF | 1 |
| Shestakova, LG | 1 |
| Krachak, DI | 1 |
| Chernookiĭ, OG | 1 |
| Zasetskiĭ, AE | 1 |
| Ostrovskiĭ, IuP | 1 |
| GHIA, G | 1 |
| MEREU, D | 1 |
| Szabó, G | 1 |
| Liaudet, L | 1 |
| Hagl, S | 1 |
| Szabó, C | 1 |
| Mego, M | 1 |
| Reckova, M | 1 |
| Obertova, J | 1 |
| Sycova-Mila, Z | 1 |
| Brozmanova, K | 1 |
| Mardiak, J | 1 |
| Qiu, Y | 1 |
| Galiñanes, M | 1 |
| Hearse, DJ | 1 |
| Nakae, I | 1 |
| Quan, L | 1 |
| Sugimoto, Y | 1 |
| Tsutamoto, T | 1 |
| Kinoshita, M | 1 |
| Schlepper, M | 1 |
| Thormann, J | 1 |
| Berwing, K | 1 |
| Strasser, R | 1 |
| Mitrovic, V | 1 |
| Knight, C | 1 |
| Purcell, H | 1 |
| Fox, K | 1 |
| Saito, S | 1 |
| Mizumura, T | 1 |
| Takayama, T | 1 |
| Honye, J | 1 |
| Fukui, T | 1 |
| Kamata, T | 1 |
| Moriuchi, M | 1 |
| Hibiya, K | 1 |
| Tamura, Y | 1 |
| Ozawa, Y | 1 |
| Ribeiro, C | 1 |
| Kodama, K | 1 |
| Adachi, H | 1 |
| Mori, N | 1 |
| Saito, I | 1 |
| Shetty, K | 1 |
| Specchia, G | 2 |
| Marsico, F | 2 |
| Laudisa, ML | 1 |
| Popescu, LM | 1 |
| Musat, S | 1 |
| Trifan, OC | 1 |
| Leabu, M | 1 |
| Tigaret, CM | 1 |
| Popescu, M | 1 |
| Popescu, A | 1 |
| Hinescu, ME | 1 |
| Moraru, II | 1 |
| Das, DK | 1 |
| Yamazaki, J | 2 |
| Iida, M | 2 |
| Igarashi, M | 1 |
| Hosoi, H | 2 |
| Ishiguro, S | 1 |
| Hou, M | 1 |
| Morishita, T | 2 |
| Nakano, H | 2 |
| Yabe, Y | 2 |
| Koyama, N | 2 |
| Hellwig, B | 1 |
| Cavero, I | 2 |
| Premmereur, J | 1 |
| Iwamoto, T | 1 |
| Miura, T | 1 |
| Urabe, K | 1 |
| Itoya, M | 1 |
| Shimamoto, K | 1 |
| Iimura, O | 1 |
| Orita, H | 1 |
| Fukasawa, M | 1 |
| Hirooka, S | 1 |
| Minowa, T | 1 |
| Uchino, H | 1 |
| Washio, M | 1 |
| Nakaya, H | 1 |
| Auchampach, JA | 3 |
| Gross, GJ | 3 |
| Suryapranata, H | 1 |
| Warltier, DC | 1 |
| Ohsawa, H | 1 |
| Uchi, T | 1 |
| Komatsu, H | 1 |
| Menasché, P | 2 |
| Kevelaitis, E | 1 |
| Mouas, C | 2 |
| Grousset, C | 2 |
| Piwnica, A | 1 |
| Bloch, G | 1 |
| Galiè, N | 1 |
| Guarnieri, C | 1 |
| Ussia, GP | 1 |
| Zimarino, M | 1 |
| Traini, AM | 1 |
| Parlangeli, R | 1 |
| Vaona, I | 1 |
| Branzi, A | 1 |
| Magnani, B | 1 |
| Miyazaki, T | 3 |
| Moritani, K | 3 |
| Miyoshi, S | 3 |
| Asanagi, M | 2 |
| Zhao, LS | 1 |
| Mitamura, H | 1 |
| Ogawa, S | 3 |
| Vegh, A | 1 |
| Györgyi, K | 1 |
| Papp, JG | 1 |
| Sakai, K | 1 |
| Parratt, JR | 1 |
| Takahashi, T | 1 |
| Takahashi, K | 1 |
| Kishi-Tanikawa, S | 1 |
| Tsuchida, K | 1 |
| Araki, H | 1 |
| Higuchi, S | 1 |
| Grover, GJ | 2 |
| Kitakaze, M | 1 |
| Minamino, T | 1 |
| Node, K | 1 |
| Komamura, K | 1 |
| Shinozaki, Y | 1 |
| Chujo, M | 2 |
| Mori, H | 1 |
| Inoue, M | 1 |
| Hori, M | 1 |
| Kamada, T | 1 |
| Perrone Filardi, P | 1 |
| Chiariello, M | 1 |
| Micheletti, T | 1 |
| Bona, M | 1 |
| Kawamura, S | 1 |
| Hayashida, M | 1 |
| Orii, R | 1 |
| Sawamura, S | 1 |
| Komatsu, K | 1 |
| Ito, N | 1 |
| Kuzumi, E | 1 |
| Hanaoka, K | 1 |
| Critz, SD | 1 |
| Liu, GS | 1 |
| Downey, JM | 1 |
| Chen, JW | 1 |
| Lee, WL | 1 |
| Hsu, NW | 1 |
| Lin, SJ | 1 |
| Ting, CT | 1 |
| Wang, SP | 1 |
| Chang, MS | 1 |
| Piriou, V | 1 |
| Ross, S | 1 |
| Pigott, D | 1 |
| Evans, R | 1 |
| Foex, P | 1 |
| Rioufol, G | 1 |
| Ovize, M | 1 |
| Loufoua, J | 1 |
| Pop, C | 1 |
| André-Fouät, X | 1 |
| Minaire, Y | 1 |
| Shinohara, H | 1 |
| Nishikado, A | 1 |
| Wakatsuki, T | 1 |
| Sakabe, K | 1 |
| Ito, S | 1 |
| Krumenacker, M | 1 |
| Roland, E | 1 |
| Sasaki, J | 1 |
| Saeki, Y | 1 |
| Kawasaki, K | 1 |
| Umeno, M | 1 |
| Ikeda, K | 1 |
| Handa, K | 1 |
| Arakawa, K | 1 |
9 reviews available for niacinamide and Heart Disease, Ischemic
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase activation in the reperfused myocardium.
Topics: Animals; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Humans; Models, Animal; Myocardial I | 2004 |
Effects of nicorandil on regional perfusion and left ventricular function.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Circulation; Echocardiography; Humans; Myocardial Ischemia | 1995 |
Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Hemodynamics; Humans; Myocardial Ischemia; Niacina | 1995 |
Prescribing for angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Humans; Myocardial | 1994 |
[Potassium agonists].
Topics: Animals; Benzopyrans; Calcium; Cromakalim; Humans; Membrane Potentials; Muscle, Smooth, Vascular; My | 1994 |
[Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Cromakalim; G | 1993 |
Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
Topics: Administration, Sublingual; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug | 1993 |
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion.
Topics: Animals; ATP-Binding Cassette Transporters; Benzopyrans; Cromakalim; Guanidines; Humans; Ischemic Pr | 1997 |
Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
Topics: Diltiazem; Hemodynamics; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Potassium Channels; V | 1992 |
5 trials available for niacinamide and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Effect of cytoflavin on the recovery of cognitive function after the cardiaс surgery with artificial blood circulation].
Topics: Assisted Circulation; Cognition; Cognition Disorders; Drug Combinations; Female; Flavin Mononucleoti | 2011 |
Antiischemic effects of nicorandil during coronary angioplasty in humans.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Blood Pressure; Coronary Angiography; | 1995 |
[Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cross-Over Studies; Dose-Response Relationship, Drug; | 1995 |
Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
Topics: Administration, Oral; Aged; Angina Pectoris; Coronary Angiography; Cross-Over Studies; Double-Blind | 1997 |
A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease.
Topics: Aged; Apolipoproteins; Diltiazem; Female; Humans; Lipids; Lipoproteins; Male; Middle Aged; Myocardia | 1992 |
39 other studies available for niacinamide and Heart Disease, Ischemic
| Article | Year |
|---|---|
Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.
Topics: Animals; Aza Compounds; Brain Ischemia; Dogs; Enzyme Inhibitors; Haplorhini; Humans; In Vitro Techni | 2003 |
Nicotinamide protects chronic hypoxic myocardial cells through regulating mTOR pathway and inducing autophagy.
Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Protein 5; Cardiotonic Agents; Caspase 3; Cell Hypo | 2019 |
Cardiovascular toxicity of multi-tyrosine kinase inhibitors in advanced solid tumors: a population-based observational study.
Topics: Adult; Aged, 80 and over; Canada; Cardiovascular Diseases; Female; Humans; Indoles; Male; Middle Age | 2015 |
Effects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.
Topics: Animals; Cardiotonic Agents; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, T | 2016 |
¹H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure.
Topics: Acetic Acid; Acetone; Aged; Case-Control Studies; Cytosine; Energy Metabolism; Female; Glycine; Hear | 2011 |
[CLINICAL OBSERVATIONS AND THERAPEUTIC RESULTS IN SUBJECTS WITH ISCHEMIC CARDIOPATHY TREATED WITH AN ENZYME COMPLEX ASSOCIATED WITH A VASODILATOR DRUG].
Topics: Adenosine Triphosphate; Coronary Disease; Drug Therapy; Electrocardiography; Flavin Mononucleotide; | 1964 |
Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.
Topics: Aged; Atrial Fibrillation; Benzenesulfonates; Carcinoma, Renal Cell; Cardiovascular Diseases; Chest | 2007 |
Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia.
Topics: Animals; Cardioplegic Solutions; Coronary Circulation; Dose-Response Relationship, Drug; Heart; Hear | 1995 |
Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
Topics: Adenosine Triphosphate; Animals; Arginine; Benzopyrans; Coronary Circulation; Coronary Vessels; Crom | 1994 |
[Therapeutic application of myocardial cytoprotection].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Hum | 1994 |
Effects of a novel, selective and potent phosphodiesterase type V inhibitor, E4021, on myocardial ischemia in guinea pigs.
Topics: Animals; Drug Interactions; Electrocardiography; Guinea Pigs; Injections, Intravenous; Isosorbide Di | 1994 |
[K-channel activators and cardioprotection].
Topics: Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Potassium Channels | 1993 |
K(+)-channel openers protect the myocardium against ischemia-reperfusion injury.
Topics: Animals; In Vitro Techniques; Lipid Metabolism; Myocardial Ischemia; Myocardial Reperfusion Injury; | 1994 |
Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Antihypertensive Ag | 1994 |
Evolving Issues in the Treatment of Ischaemic Heart Disease: The Potassium Channel Openers. Symposium proceedings. Barcelona, Spain, 2 September 1992.
Topics: Animals; Anti-Arrhythmia Agents; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Potassium Cha | 1993 |
ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
Topics: Benzopyrans; Cromakalim; Dihydropyridines; Guanidines; Humans; Myocardial Ischemia; Myocardium; Niac | 1994 |
Effect of nicorandil on post-ischaemic contractile dysfunction in the heart: roles of its ATP-sensitive K+ channel opening property and nitrate property.
Topics: Adenosine Triphosphate; Animals; Glyburide; Hemodynamics; Infusions, Intravenous; Ion Channel Gating | 1993 |
Prevention of postischemic reperfusion injury: the improvement of myocardial tissue blood flow after ischemia by terminal nicorandil-Mg cardioplegia.
Topics: Animals; Blood Flow Velocity; Carbon Dioxide; Cardioplegic Solutions; Coronary Vessels; Dogs; Glucos | 1993 |
Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Coronary Circulation; Dihydropyridines; Dogs; Female; | 1993 |
Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Dogs; Glyburide; Myocardial Contraction; Myoc | 1993 |
Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Circu | 1993 |
Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection?
Topics: Animals; Coronary Circulation; Glyburide; Heart Arrest, Induced; Male; Myocardial Ischemia; Myocardi | 1995 |
Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs.
Topics: Animals; Blood Pressure; Cardiac Output; Female; Glutathione; Heart Rate; Isosorbide Dinitrate; Male | 1995 |
Nicorandil augments regional ischemia-induced monophasic action potential shortening and potassium accumulation without serious proarrhythmia.
Topics: Action Potentials; Animals; Coronary Circulation; Dogs; Myocardial Ischemia; Niacinamide; Nicorandil | 1995 |
Is potassium channel opening an effective form of preconditioning before cardioplegia?
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Volume; Cardioplegic Solutions; Coronary Circ | 1996 |
Different responses of epicardium and endocardium to KATP channel modulators during regional ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Decanoic Acids; Dogs; Endocardium; Hydroxy Acids | 1996 |
Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Circulation; Dogs; E | 1996 |
Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
Topics: Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Diltiaze | 1996 |
Mechanisms of action of various ATP-sensitive potassium channel openers.
Topics: Adenosine Triphosphate; Animals; Dogs; Ion Channel Gating; Myocardial Ischemia; Niacinamide; Nicoran | 1996 |
Role of activation of ectosolic 5'-nucleotidase in the cardioprotection mediated by opening of K+c channels.
Topics: 5'-Nucleotidase; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dogs; Enzyme Activation; | 1996 |
[Potassium channel activators: hemodynamic effects at the systemic and coronary level].
Topics: Animals; Coronary Circulation; Hemodynamics; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; P | 1995 |
[Successful treatment of intraoperative myocardial ischemia with nicorandil].
Topics: Aged; Aged, 80 and over; Anesthesia; Female; Humans; Injections, Intravenous; Intraoperative Complic | 1997 |
Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes.
Topics: Adenosine Triphosphate; Animals; Cell Death; Disease Models, Animal; Electrophysiology; Female; Guan | 1997 |
Beneficial effect of concomitant administration of isoflurane and nicorandil.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Drug Therapy, Co | 1997 |
Ventricular fibrillation in preconditioned pig hearts: role of K+ATP channels.
Topics: Action Potentials; Animals; Blood Glucose; Blood Pressure; Glyburide; Heart; Heart Rate; Ischemic Pr | 1997 |
Differential role of epicardial and endocardial K(ATP) channels in potassium accumulation during regional ischemia induced by embolization of a coronary artery with latex.
Topics: Adenosine Triphosphate; Algorithms; Animals; Coronary Vessels; Dogs; Embolization, Therapeutic; Endo | 1998 |
The effects of nicorandil on electrophysiological changes in acute myocardial ischemia and reperfusion.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Drug Evaluation, Precl | 1998 |
Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Dogs; Female; | 1992 |
Evolving Issues in the Treatment of Angina Pectoris. Nicorandil: The 1st Potassium-Channel Activator in Ischemic Heart Disease. Proceedings of an International Workshop. Taormina, Sicily, May 8-12, 1991.
Topics: Animals; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Potassium Channels | 1992 |